Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of mRNA Cancer Vaccines and Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of mRNA Cancer Vaccines and Therapeuticsmarket, defines the market attractiveness level of mRNA Cancer Vaccines and Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of mRNA Cancer Vaccines and Therapeutics industry, describes the types of mRNA Cancer Vaccines and Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global mRNA Cancer Vaccines and Therapeutics market and the development prospects and opportunities of mRNA Cancer Vaccines and Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global mRNA Cancer Vaccines and Therapeutics market in Chapter 13.
By Player:
Ethris
eTheRNA
Translate Bio
Sangamo Therapeutics
CureVac
Moderna Therapeutics
In-Cell-Art
Tiba Biotechnology
BioNTech
Argos Therapeutics
By Type:
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
By End-User:
Infectious Disease
Cancer
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 mRNA Cancer Vaccines and Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 mRNA Cancer Vaccines and Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 mRNA Cancer Vaccines and Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 mRNA Cancer Vaccines and Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise mRNA Cancer Vaccines and Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global mRNA Cancer Vaccines and Therapeutics Consumption (2017-2022)
-
7.2 United States mRNA Cancer Vaccines and Therapeutics Consumption (2017-2022)
-
7.3 Europe mRNA Cancer Vaccines and Therapeutics Consumption (2017-2022)
-
7.4 China mRNA Cancer Vaccines and Therapeutics Consumption (2017-2022)
-
7.5 Japan mRNA Cancer Vaccines and Therapeutics Consumption (2017-2022)
-
7.6 India mRNA Cancer Vaccines and Therapeutics Consumption (2017-2022)
-
7.7 South Korea mRNA Cancer Vaccines and Therapeutics Consumption (2017-2022)
8 Region and Country-wise mRNA Cancer Vaccines and Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global mRNA Cancer Vaccines and Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States mRNA Cancer Vaccines and Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe mRNA Cancer Vaccines and Therapeutics Consumption Forecast (2022-2028)
-
8.4 China mRNA Cancer Vaccines and Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan mRNA Cancer Vaccines and Therapeutics Consumption Forecast (2022-2028)
-
8.6 India mRNA Cancer Vaccines and Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea mRNA Cancer Vaccines and Therapeutics Consumption Forecast (2022-2028)
9 Global mRNA Cancer Vaccines and Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global mRNA Cancer Vaccines and Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Adeno Carcinomas Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Mucinous Carcinomas Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Adenosquamous Carcinomas Consumption and Growth Rate (2017-2022)
-
9.2 Global mRNA Cancer Vaccines and Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Infectious Disease Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global mRNA Cancer Vaccines and Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global mRNA Cancer Vaccines and Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Adeno Carcinomas Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Mucinous Carcinomas Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Adenosquamous Carcinomas Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global mRNA Cancer Vaccines and Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global mRNA Cancer Vaccines and Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global mRNA Cancer Vaccines and Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global mRNA Cancer Vaccines and Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 mRNA Cancer Vaccines and Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global mRNA Cancer Vaccines and Therapeutics Market Competitive Analysis
-
14.1 Ethris
-
14.1.1 Ethris Company Details
-
14.1.2 Ethris mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Ethris mRNA Cancer Vaccines and Therapeutics Product and Service
-
14.2 eTheRNA
-
14.2.1 eTheRNA Company Details
-
14.2.2 eTheRNA mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Product and Service
-
14.3 Translate Bio
-
14.3.1 Translate Bio Company Details
-
14.3.2 Translate Bio mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Product and Service
-
14.4 Sangamo Therapeutics
-
14.4.1 Sangamo Therapeutics Company Details
-
14.4.2 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Service
-
14.5 CureVac
-
14.5.1 CureVac Company Details
-
14.5.2 CureVac mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 CureVac mRNA Cancer Vaccines and Therapeutics Product and Service
-
14.6 Moderna Therapeutics
-
14.6.1 Moderna Therapeutics Company Details
-
14.6.2 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Service
-
14.7 In-Cell-Art
-
14.7.1 In-Cell-Art Company Details
-
14.7.2 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product and Service
-
14.8 Tiba Biotechnology
-
14.8.1 Tiba Biotechnology Company Details
-
14.8.2 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product and Service
-
14.9 BioNTech
-
14.9.1 BioNTech Company Details
-
14.9.2 BioNTech mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 BioNTech mRNA Cancer Vaccines and Therapeutics Product and Service
-
14.10 Argos Therapeutics
-
14.10.1 Argos Therapeutics Company Details
-
14.10.2 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of mRNA Cancer Vaccines and Therapeutics
-
Figure mRNA Cancer Vaccines and Therapeutics Picture
-
Table Global mRNA Cancer Vaccines and Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global mRNA Cancer Vaccines and Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global mRNA Cancer Vaccines and Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global mRNA Cancer Vaccines and Therapeutics Consumption by Country (2017-2022)
-
Figure United States mRNA Cancer Vaccines and Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe mRNA Cancer Vaccines and Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China mRNA Cancer Vaccines and Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan mRNA Cancer Vaccines and Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India mRNA Cancer Vaccines and Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea mRNA Cancer Vaccines and Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global mRNA Cancer Vaccines and Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States mRNA Cancer Vaccines and Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe mRNA Cancer Vaccines and Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China mRNA Cancer Vaccines and Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan mRNA Cancer Vaccines and Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India mRNA Cancer Vaccines and Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea mRNA Cancer Vaccines and Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adeno Carcinomas Consumption and Growth Rate (2017-2022)
-
Figure Global Mucinous Carcinomas Consumption and Growth Rate (2017-2022)
-
Figure Global Adenosquamous Carcinomas Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Adeno Carcinomas Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mucinous Carcinomas Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adenosquamous Carcinomas Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global mRNA Cancer Vaccines and Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global mRNA Cancer Vaccines and Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Ethris (Foundation Year, Company Profile and etc.)
-
Table Ethris mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ethris mRNA Cancer Vaccines and Therapeutics Product and Service
-
Table eTheRNA (Foundation Year, Company Profile and etc.)
-
Table eTheRNA mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table eTheRNA mRNA Cancer Vaccines and Therapeutics Product and Service
-
Table Translate Bio (Foundation Year, Company Profile and etc.)
-
Table Translate Bio mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Translate Bio mRNA Cancer Vaccines and Therapeutics Product and Service
-
Table Sangamo Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Service
-
Table CureVac (Foundation Year, Company Profile and etc.)
-
Table CureVac mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table CureVac mRNA Cancer Vaccines and Therapeutics Product and Service
-
Table Moderna Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Service
-
Table In-Cell-Art (Foundation Year, Company Profile and etc.)
-
Table In-Cell-Art mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product and Service
-
Table Tiba Biotechnology (Foundation Year, Company Profile and etc.)
-
Table Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product and Service
-
Table BioNTech (Foundation Year, Company Profile and etc.)
-
Table BioNTech mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioNTech mRNA Cancer Vaccines and Therapeutics Product and Service
-
Table Argos Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Service
-
